Clotrimazole and Betamethasone Dipropionate (E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Clotrimazole and Betamethasone Dipropionate drug offered from E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.. This Azole Antifungal [EPC],Azoles [Chemical/Ingredient],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | Clotrimazole and Betamethasone Dipropionate |
SUBSTANCE NAME: | CLOTRIMAZOLE; BETAMETHASONE DIPROPIONATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Azole Antifungal [EPC],Azoles [Chemical/Ingredient],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
ROUTE: | TOPICAL |
DOSAGE FORM: | CREAM |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2001-06-05 |
END MARKETING DATE: | 0000-00-00 |
Clotrimazole and Betamethasone Dipropionate HUMAN PRESCRIPTION DRUG Details:
Item Description | Clotrimazole and Betamethasone Dipropionate from E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. |
LABELER NAME: | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10; .5(mg/g; mg/g) |
START MARKETING DATE: | 2001-06-05 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0168-0258_bbda5cdd-1685-410c-a419-d0d724ef3634 |
PRODUCT NDC: | 0168-0258 |
APPLICATION NUMBER: | ANDA075502 |
Other CLOTRIMAZOLE; BETAMETHASONE DIPROPIONATE Pharmaceutical Manufacturers / Labelers: